BioCentury
ARTICLE | Distillery Techniques

Disease models

October 31, 2018 8:33 PM UTC

E-cadherin (CDH1)-deficient mice with activated PI3KCA could be used to screen therapies for invasive lobular breast carcinoma. Mice engineered to express mutant, inactive CHD1 and constitutively acti...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article